T1	Participants 636 648	340 patients
T2	Participants 1763 1834	200 patients were transplanted (33%), 30 (13%) in the intermediate-risk
T3	Participants 1491 1541	104 patients (62%) achieved a cytogenetic response
T4	Participants 1246 1353	532 patients: 200 patients (38%) were low, 239 patients (45%) intermediate, and 93 patients (17%) high risk
